NDC 81749-004

Tarpeyo

Budesonide

Tarpeyo is a Oral Capsule, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Calliditas Therapeutics Ab. The primary component is Budesonide.

• Product ID: 81749-004_eba244a0-8fb9-4859-81b6-128213b80f35
• NDC: 81749-004
• Product Type: Human Prescription Drug
• Proprietary Name: Tarpeyo
• Generic Name: Budesonide
• Dosage Form: Capsule, Delayed Release
• Route of Administration: ORAL
• Marketing Start Date: 2021-12-15
• Marketing Category: NDA /
• Application Number: NDA215935
• Labeler Name: Calliditas Therapeutics AB
• Substance Name: BUDESONIDE
• Active Ingredient Strength: 4 mg/1
• Pharm Classes: Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 81749-004-01

120 CAPSULE, DELAYED RELEASE in 1 BOTTLE (81749-004-01)

• Marketing Start Date: 2021-12-15
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Tarpeyo" or generic name "Budesonide"

NDC	Brand Name	Generic Name
0093-6815	Budesonide	Budesonide
0093-6816	Budesonide	Budesonide
0093-6817	Budesonide	Budesonide
0093-7445	Budesonide	Budesonide
0115-1687	Budesonide Inhalation	Budesonide
0115-1689	Budesonide Inhalation	Budesonide
0186-0916	PULMICORT	Budesonide
0186-0917	PULMICORT	Budesonide
0186-1988	PULMICORT RESPULES	Budesonide
0186-1989	PULMICORT RESPULES	Budesonide
0186-1990	PULMICORT RESPULES	Budesonide